These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 737094)

  • 1. Observations on intravenous administration of lignocaine in patients with myocardial infarction.
    Campbell NP; Kelly JG; Adgey AA; McDevitt DG; Pantridge JF
    Br Heart J; 1978 Dec; 40(12):1371-5. PubMed ID: 737094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lignocaine therapy after acute myocardial infarction.
    Chopra MP; Portal RW; Aber CP
    Br Med J; 1969 Jan; 1(5638):213-6. PubMed ID: 5762622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Logical approach to lignocaine therapy.
    Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F
    Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood levels of lidocaine after various infusion rates in patients with acute myocardial infarction.
    Rydén L; Waldenström A; Winsnes Y; Ortengren B
    Am Heart J; 1975 Apr; 89(4):470-3. PubMed ID: 1114978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of intramuscular lidocaine in the acute stage of myocardial infarction].
    Djiane P; Egre A; Perchicot B; Bory M; Serradimigni A; Bruguerolle B; Bouyard P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):931-8. PubMed ID: 6793010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between plasma lignocaine levels and induced haemodynamic changes.
    Binnion PF; Murtagh G; Pollock AM; Fletcher E
    Br Med J; 1969 Aug; 3(5667):390-2. PubMed ID: 5797780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic lidocaine in suspected acute myocardial infarction.
    Goodman SL; Geiderman JM; Bernstein IJ
    JACEP; 1979 Jun; 8(6):221-4. PubMed ID: 449144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration.
    Sheridan DJ; Crawford L; Rawlins MD; Julian DG
    Lancet; 1977 Apr; 1(8016):824-5. PubMed ID: 67335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative trial of mexiletine and lignocaine in the treatment of early ventricular tachyarrhythmias after acute myocardial infarction.
    Horowitz JD; Anavekar SN; Morris PM; Goble AJ; Doyle AE; Louis WJ
    J Cardiovasc Pharmacol; 1981; 3(3):409-19. PubMed ID: 6168823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between effectiveness of intramuscular and intravenous lignocaine on ventricular arrhythmia complicating acute myocardial infarction.
    Rydén L; Waldenström A; Ehn L; Holmberg S; Husaini M
    Br Heart J; 1973 Nov; 35(11):1124-31. PubMed ID: 4128310
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous administration of lidocaine and amiodarone in patients with acute myocardial infarction].
    Capucci A; Melandri G; Mantovani B; Maresta A; Magnani B
    G Ital Cardiol; 1985 Mar; 15(3):285-9. PubMed ID: 4018467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of ventricular dysrhythmias following acute myocardial infarction: a double-blind trial of continuous intravenous infusion of lignocaine.
    Baker IA; Collins JV; Evans TR
    Guys Hosp Rep; 1971; 120(1):1-7. PubMed ID: 4934490
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma levels of lidocaine after intramuscular injection and subsequent infusion in patients with acute myocardial infarction.
    Oltmanns D; Lübben C; Pentz R; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):582-4. PubMed ID: 7152740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Personal experiences with prolonged administration of drip infusions of xylocaine in the early period of myocardial infarct].
    Chetkowska E; Edelman M; Sokól M; Spolińska E
    Wiad Lek; 1971 Jun; 24(12):1201-4. PubMed ID: 5561277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lignocaine in the treatment of arrhythmia in acute myocardial infarct].
    Bolińska H; Kuczborski M
    Wiad Lek; 1971 Oct; 24(19):1851-4. PubMed ID: 5134518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lidocaine in the treatment of arrhythmia in acute myocardial infarct].
    Dunning AJ; Kettner H; Wesdorp JC
    Ned Tijdschr Geneeskd; 1969 Dec; 113(52):2319-24. PubMed ID: 5362041
    [No Abstract]   [Full Text] [Related]  

  • 19. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction.
    Koster RW; Dunning AJ
    N Engl J Med; 1985 Oct; 313(18):1105-10. PubMed ID: 3900727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program.
    Pfeifer HJ; Greenblatt DJ; Koch-Weser J
    Am Heart J; 1976 Aug; 92(2):168-73. PubMed ID: 941829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.